Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623258 · ClinicalTrials.gov registry record
A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma
A clinical trial, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- 34
- Enrollment target
NCT01623258 is a clinical trial that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT01623258 has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The objective of this trial is to define the rate of upstaging of colon carcinoma lymph node metastasis with sentinel lymph node (SLN) mapping. Null hypothesis: There is no difference in the rate of lymph node metastasis between conventional histopathological processing of lymph nodes and SLN mapping with detailed pathologic examination using immunohistochemistry (IHC) in patients undergoing resection of colon carcinoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2002-12 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01623258
The ClinicalTrials.gov registry entry for NCT01623258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01623258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01623258 about?
NCT01623258 is a clinical study titled "A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma". The objective of this trial is to define the rate of upstaging of colon carcinoma lymph node metastasis with sentinel lymph node (SLN) mapping. Null hypothesis: There is no difference in the rate of lymph node metastasis between conventional histopathological processing of lymph nodes and SLN mappi...
What is the current status of trial NCT01623258?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2002-12. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01623258?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.